Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGT001-075 in Obesity or Overweight with Comorbidities
NCT06867718Phase 2Completed
- Sponsor
- Regor Therapeutics
- Start
- Jan 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RGT-075 in obesity, sponsored by Regor Therapeutics. Started Jan 2025; status: completed.
02
Drugs
RGT-075
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06867718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06867718.